Surgery, Gastroenterology and Oncology
Vol. 21, No. 3, Sept 2016
Human Cancers: The Interplay Between Protein-Coding Genes and Non-Coding RNAs
George A. Calin
Leading article, Sept 2016
Article DOI: 10.21614/jtmr-21-3-90
The discovery of non-coding RNAs (ncRNAs) dramatically changed the understanding of cancer mechanisms in the last decade. The ncRNAs interplay with protein-coding genes and their abnormalities represents one the most unexpected and important discoveries in the cancer field.
Cancer initiation, progression and dissemination causally involve the effects of small regulatory ncRNAs named microRNAs, mainly due to deregulation of expression of cancer protein coding genes. miRNAs can act as oncogenes (activating malignant potential) or tumor suppressors (inhibiting malignant potential) directly on the tumor cells or via communication with tumor microenvironment cells.
Understanding the roles of miRNAs and other ncRNAs in malignant cells uncovers a new layer of protein coding and non-coding gene regulation; furthermore, provides new markers for early diagnosis and improved prognosis, as well as novel therapeutics for cancer patients.

Herein I will expose what is known about the miRNA function and describe examples and the challenges for clinical use of miRNAs in the near future.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 1697

Watch Video Articles

For Authors

Journal Subscriptions

Current Issue

Sept 2023


Instructions for authors
Online submission
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2

Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: